Related Experiment Video
Updated: Aug 6, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
PER-14, a β-lactamase variant with reduced sensitivity to avibactam and relebactam
Melina Ruggiero1,2, Melina García Alonso1, Salvador I Drusin3,4
1Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Buenos Aires, Argentina.
Abstract:
PER-1-producing Pseudomonas and Acinetobacter and PER-2-producing Enterobacterales, respectively, are increasingly difficult to treat due to combined resistance to antibiotics like ceftazidime, cefiderocol, and ceftazidime/aztreonam-avibactam, among others. PER-14 differs from PER-2 by an S130T substitution. Through combined functional and in silico analyses, we demonstrated that PER-14 is resistant to avibactam and relebactam inhibition while retaining an extended-spectrum activity and the ability to hydrolyze cefiderocol, as the S130T substitution affects the proper binding of the DBOs.
Insights
New PER-14 enzymes in bacteria like Pseudomonas and Acinetobacter resist common antibiotics, including cefiderocol. This resistance stems from a specific S130T substitution, impacting drug binding and treatment options.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Discovery
Background:
- PER-1 and PER-2 enzymes confer resistance to critical antibiotics in Gram-negative bacteria.
- Increasing antibiotic resistance necessitates understanding novel resistance mechanisms.
Purpose of the Study:
- To characterize the novel PER-14 beta-lactamase and its resistance profile.
- To elucidate the structural basis for PER-14's resistance to avibactam and relebactam.
Main Methods:
- Functional enzyme assays to determine hydrolysis profiles.
- In silico modeling to analyze inhibitor binding.
- Site-directed mutagenesis to confirm the role of the S130T substitution.
Main Results:
- PER-14 exhibits resistance to avibactam and relebactam.
- The S130T substitution is crucial for PER-14's resistance to these inhibitors.
- PER-14 retains extended-spectrum activity and hydrolyzes cefiderocol.
Conclusions:
- PER-14 represents a significant challenge in treating infections caused by resistant bacteria.
- The S130T substitution alters the binding of beta-lactamase-directed inhibitors.
- Further research is needed to develop new therapeutic strategies against PER-14-producing bacteria.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
Antibiotic Selection
Acute Pyelonephritis II: Diagnostic Studies and Management
